Sonoma Pharmaceuticals, Inc.

SNOA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$1-$1-$1-$1
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0-$1$1$1
Other Non-Cash$0-$0$0-$0
Operating Cash Flow-$0-$2$1$0
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$0$0$1$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0-$0$1$1
Forex Effect$0$0-$0-$0
Net Chg. in Cash$0-$2$1$1
Supplemental Information
Beg. Cash$5$5$4$3
End Cash$5$4$5$4
Free Cash Flow-$0-$2$1$0
Sonoma Pharmaceuticals, Inc. (SNOA) Financial Statements & Key Stats | AlphaPilot